Simplex Trading, LLC Mirum Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	SELL	$24.92 - $30.02 $78,248 - $94,262	-3,140 Reduced 52.1%	2,887 $72,000
Q4 2023 Feb 02, 2024	BUY	$27.14 - $34.93 $163,572 - $210,523	6,027 New	6,027 $177,000
Q2 2023 Aug 04, 2023	BUY	$23.51 - $30.09 $39,355 - $50,370	1,674 New	1,674 $43,000
Q4 2022 Feb 02, 2023	BUY	$17.59 - $23.83 $52,347 - $70,918	2,976 Added 2439.34%	3,098 $60,000
Q3 2022 Nov 04, 2022	BUY	$19.98 - $29.44 $2,437 - $3,591	122 New	122 $2,000
Q1 2022 May 02, 2022	SELL	$15.5 - $23.93 $17,174 - $26,514	-1,108 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$13.05 - $19.35 $14,459 - $21,439	1,108 New	1,108 $17,000

192

54M

177K

167K

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $1.73B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.